{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Most studies were single-centre observational cohorts from high-income countries, with no randomised trials identified."
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Most studies were single-centre observational cohorts from high-income countries, with no randomised trials identified."
      },
      "Participants": {
        "score": 1,
        "evidence": "for studies on preoperative GLP-1 RA use in adults undergoing elective surgery."
      },
      "Intervention": {
        "score": 2,
        "evidence": "31.9% (n = 30,981) received preoperative GLP-1 RA therapy."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the safety and efficacy of preoperative glucagon-like peptide-1 receptor agonists (GLP-1 RA) in elective surgical systems."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was perioperative safety, defined as any complication within 90 days post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Most studies were single-centre observational cohorts from high-income countries, with no randomised trials identified."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Most studies were single-centre observational cohorts from high-income countries, with no randomised trials identified."
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Most studies were single-centre observational cohorts from high-income countries, with no randomised trials identified."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "A total of 21 studies, involving 97,059 patients, met inclusion criteria; 31.9% (n = 30,981) received preoperative GLP-1 RA therapy."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Postoperative complications were reported in 12 studies, with no increased risk in GLP-1 users (pooled OR: 0.78, 95% CI: 0.59\u20131.05)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Postoperative complications were reported in 12 studies, with no increased risk in GLP-1 users."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The study is registered with PROSPERO, CRD420251027809."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: NIHR Doctoral Research Fellowship and NIHR Exeter Biomedical Research Centre Senior Investigator Fellowship."
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}